Covid-19 roundup: Pfizer submits EUA for Omicron-targeted booster; Novavax EUA expands to teens
The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an EUA for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older.
The application’s submission comes as BioNTech said earlier this month that it expects to begin delivering Omicron-adapted vaccines as early as October, subject to regulatory approval.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.